海角社区

News

Demonstrating Excellence in Outcomes and Culture

Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Home / News / Specialty Pharmacy / Page 4

Specialty Pharmacy | News

Stay up to date with the latest innovations, company updates, and industry insights as we work to advance health and wellness for all.

Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

TRUQAP™ (capivasertib) Now Available from Onco360

FRUZAQLA™ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)

WHAT PEOPLE ARE SAYING